19 Mar 2021 A new collaborative project bringing together efforts for the treatment of corneal opacification in aniridia patients.
A budget of 1.4 million € has been recently granted by the EJP RD (for European Joint Research Program on Rare Diseases) to continue to push forward research on the treatment of aniridia-associated keratopathy (AAK), which is the most difficult part of the disease to treat. The AAK-INSIGHT project was proposed by a consortium of researchers from several countries, led by Prof. Neil Lagali (Linköping University, Sweden) and Prof. Daniel Aberdam (CNRS, Biologie, Inserm-Technion, France). The AAK-INSIGHT project aims to implement a drug development program for a gene therapy medicinal product for aniridia-associated keratopathy, eventually leading to the approval of a first-in-human clinical trial. The research consortium comprises 6 active members of AniridiaNet #CA18116 Action connecting research initiatives across Europe...